Latest News and Press Releases
Want to stay updated on the latest news?
-
BENSALEM, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Brown-Forman Corporation (“Brown-Forman” or the “Company”) (NYSE: BF.A, BF.B)...
-
LOS ANGELES, June 18, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Neogen Corporation (“Neogen”...
-
시드니, June 19, 2025 (GLOBE NEWSWIRE) -- 선도적인 온라인 FX 및 CFD 브로커 Axi가 세계적으로 인정받는 금융 서비스 및 미디어 기업인 블룸버그 (Bloomberg)와 파트너십을 체결한다고 발표했다. 이 전략적 협력은 글로벌 무대에서 강력한 브랜드 인지도와 신뢰도를 구축하기 위한 Axi의 지속적인 노력이 중요한 진전을...
-
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Compass Diversified Holdings...
-
Washington, DC, June 18, 2025 (GLOBE NEWSWIRE) -- Global law firm Norton Rose Fulbright has sharpened its competitive edge in tax and corporate transactions with the arrival of Washington,...
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caleres, Inc. - CAL
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Caleres, Inc. (“Caleres” or the “Company”) (NYSE: CAL). Such investors are advised to...
-
Transaction in Own Shares 18 June, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 18 June, 2025 it purchased the following number of Shares for cancellation. ...
-
Glendale, California, June 18, 2025 (GLOBE NEWSWIRE) -- Radcred, a trusted name in online financial services, has officially announced the launch of its enhanced digital platform, offering $255...
-
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sanofi (“Sanofi” or the “Company”) (NASDAQ: SNY). Such investors are advised to contact...
-
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT). Such investors are...